Moderna starts Covid-19 vaccine trials for children

Moderna on Tuesday said it has started its Covid-19 vaccine trials for children aged 6 months to under 12 years, with plans to enroll about 6,750 participants.

“We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada,” said CEO Stephane Bancel in a statement.

“This pediatric study will help us assess the potential safety and immunogenicity of our Covid-19 vaccine candidate in this important younger age population.”


Arab News

Related Articles

Back to top button